0001437749-22-004667.txt : 20220228
0001437749-22-004667.hdr.sgml : 20220228
20220228171556
ACCESSION NUMBER: 0001437749-22-004667
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220224
FILED AS OF DATE: 20220228
DATE AS OF CHANGE: 20220228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: QUAY STEVEN C
CENTRAL INDEX KEY: 0001008227
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35610
FILM NUMBER: 22691416
MAIL ADDRESS:
STREET 1: 22026 20TH AVENUE S E
STREET 2: SUITE 102
CITY: BOTHELL
STATE: WA
ZIP: 98021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ATOSSA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001488039
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264753208
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 107 SPRING STREET
CITY: SEATTLE
STATE: WA
ZIP: 98104
BUSINESS PHONE: 206.588.0256
MAIL ADDRESS:
STREET 1: 107 SPRING STREET
CITY: SEATTLE
STATE: WA
ZIP: 98104
FORMER COMPANY:
FORMER CONFORMED NAME: ATOSSA GENETICS INC
DATE OF NAME CHANGE: 20100325
4
1
rdgdoc.xml
FORM 4
X0306
4
2022-02-24
0001488039
ATOSSA THERAPEUTICS, INC.
ATOS
0001008227
QUAY STEVEN C
C/O ATOSSA THERAPEUTICS, INC.
107 SPRING STREET
SEATTLE
WA
98104
1
1
President & CEO
Stock Option (right to buy)
1.25
2022-02-24
4
A
0
1900000
0
A
2032-02-24
Common Stock
1900000
1900000
D
The options will vest on a quarterly basis over two (2) years.
/s/ Steven Quay
2022-02-28